| Ucb S.a. | 6,605 | US$1.94M | 4.7% |
| Lifestance Health Group, Inc. | 227K | US$1.75M | 4.3% |
| Danaher Corporation | 7,675 | US$1.4M | 3.4% |
| 10x Genomics, Inc. | 45,000 | US$1.27M | 3.1% |
| Intuitive Surgical, Inc. | 2,816 | US$1.2M | 2.9% |
| Cogent Biosciences, Inc. | 33,428 | US$1.17M | 2.9% |
| Alnylam Pharmaceuticals, Inc. | 3,791 | US$1.14M | 2.8% |
| Argenx Se | 1,365 | US$1.14M | 2.8% |
| Unitedhealth Group Incorporated | 2,424 | US$922K | 2.2% |
| Bio-techne Corp | 17,786 | US$919K | 2.2% |
| Ascendis Pharma A/s | 3,865 | US$866K | 2.1% |
| Edwards Lifesciences Corporation | 10,000 | US$865K | 2.1% |
| Moderna, Inc. | 18,282 | US$863K | 2.1% |
| Kymera Therapeutics, Inc. | 10,000 | US$814K | 2.0% |
| Xenon Pharmaceuticals Inc. | 14,366 | US$786K | 1.9% |
| Heartflow, Inc. | 24,994 | US$774K | 1.9% |
| Sartorius Stedim Biotech Sa | 3,633 | US$755K | 1.8% |
| Insmed Incorporated | 6,875 | US$735K | 1.8% |
| Veeva Systems Inc. | 4,188 | US$730K | 1.8% |
| Vaxcyte, Inc. | 14,071 | US$723K | 1.8% |
| Revolution Medicines, Inc. | 4,504 | US$709K | 1.7% |
| Caris Life Sciences, Inc. | 41,991 | US$702K | 1.7% |
| Crinetics Pharmaceuticals, Inc. | 19,000 | US$675K | 1.6% |
| Axsome Therapeutics, Inc. | 2,752 | US$645K | 1.6% |
| Cytokinetics, Incorporated | 8,262 | US$634K | 1.5% |
| Veracyte, Inc. | 13,621 | US$631K | 1.5% |
| Thermo Fisher Scientific Inc | 1,276 | US$628K | 1.5% |
| Brightspring Health Services, Inc. | 10,187 | US$628K | 1.5% |
| Privia Health Group, Inc. | 28,119 | US$605K | 1.5% |
| Boston Scientific Corporation | 12,185 | US$589K | 1.4% |
| Natera, Inc. | 2,615 | US$584K | 1.4% |
| Kiniksa Pharmaceuticals International, Plc | 12,000 | US$581K | 1.4% |
| Guardant Health, Inc. | 4,375 | US$567K | 1.4% |
| Stryker Corporation | 1,832 | US$559K | 1.4% |
| Viridian Therapeutics, Inc. | 31,100 | US$548K | 1.3% |
| Alignment Healthcare, Inc. | 33,378 | US$511K | 1.2% |
| Lonza Group Ag | 780 | US$500K | 1.2% |
| Nuvalent, Inc. | 4,504 | US$497K | 1.2% |
| Stoke Therapeutics, Inc. | 15,670 | US$484K | 1.2% |
| Disc Medicine, Inc. | 6,926 | US$482K | 1.2% |
| Dexcom, Inc. | 6,533 | US$482K | 1.2% |
| Insulet Corporation | 3,112 | US$451K | 1.1% |
| Eli Lilly And Company | 395 | US$436K | 1.1% |
| Enliven Therapeutics, Inc. | 10,703 | US$424K | 1.0% |
| Cytomx Therapeutics, Inc. | 112K | US$403K | 0.98% |
| Waystar Holding Corp. | 20,187 | US$402K | 0.98% |
| Irhythm Holdings, Inc. | 3,471 | US$395K | 0.96% |
| Kestra Medical Technologies, Ltd. | 18,400 | US$391K | 0.95% |
| Newamsterdam Pharma Company N.v. | 11,122 | US$375K | 0.91% |
| Amylyx Pharmaceuticals, Inc. | 23,554 | US$338K | 0.82% |
| Roivant Sciences Ltd. | 11,250 | US$337K | 0.82% |
| Align Technology, Inc. | 1,863 | US$326K | 0.80% |
| Repligen Corporation | 2,485 | US$308K | 0.75% |
| Zai Lab Ltd. | 153K | US$270K | 0.66% |
| Mirum Pharmaceuticals, Inc. | 2,191 | US$222K | 0.54% |
| Upstream Bio, Inc. | 24,900 | US$208K | 0.51% |
| Relay Therapeutics, Inc. | 12,996 | US$183K | 0.45% |
| Zenas Biopharma, Inc. | 9,817 | US$181K | 0.44% |
| Viking Therapeutics, Inc. | 5,422 | US$178K | 0.43% |
| Procept Biorobotics Corporation | 6,656 | US$175K | 0.43% |
| Janux Therapeutics, Inc. | 11,754 | US$171K | 0.42% |
| Outset Medical, Inc. | 34,000 | US$166K | 0.41% |
| Mbx Biosciences, Inc. | 5,128 | US$161K | 0.39% |
| Olema Pharmaceuticals, Inc. | 11,250 | US$148K | 0.36% |
| Oruka Therapeutics, Inc. | 1,000 | US$58,530 | 0.14% |
| Spyre Therapeutics, Inc. | 300 | US$22,050 | 0.05% |
| Doximity, Inc. | 0 | US$0 | 0.00% |
| Penumbra, Inc. | 0 | US$0 | 0.00% |
| Resmed Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Wave Life Sciences Ltd. | 0 | US$0 | 0.00% |